Weight management involves a personalized treatment plan that may be based on lifestyle and dietary changes alongside pharmacological therapy. Within this framework, on November 3, 2026, Harokopio University launched “My NutriPath” — a free teleconsultation service with a registered dietitian-nutritionist for patients beginning treatment with any of the available approved injectable therapies for obesity management. The service is implemented with the sponsorship support of Pharmaserv-Lilly.
Every individual with obesity enrolled in My NutriPath will receive 5 teleconsultation sessions within the first 6 months, including a personalized nutrition plan, education on sustainable lifestyle changes, and guidance tailored to their individual needs and therapeutic goals. An additional telephone evaluation session will follow in the first year after enrollment in the service.
Pharmaserv-Lilly backs the initiative
The service is intended for patients on any injectable therapy indicated for the treatment of obesity. Referral is made by the treating physician at the start of treatment, in accordance with approved starting doses, and requires a BMI ≥ 30 kg/m² or a BMI ≥ 27 and < 30 kg/m² with at least one comorbidity (e.g., hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease, prediabetes, or type 2 diabetes). A dedicated informational leaflet has been developed for healthcare professionals.
Through My NutriPath, patients will have access to a specialized dietitian-nutritionist who will guide them with a personalized nutrition plan. Pharmaserv-Lilly’s support for this initiative reinforces a more holistic approach to obesity patient care, combining dietary and lifestyle intervention with pharmacological treatment.
